Recombinant Blaberus giganteus Hypertrehalosaemic factor

What is Blaberus giganteus Hypertrehalosaemic factor and how does it compare to similar factors in other cockroach species?

Blaberus giganteus Hypertrehalosaemic factor is a neuropeptide hormone (also known as Adipokinetic hormone 1 or BlaGi-AKH-1) that increases hemolymph carbohydrate (trehalose) levels in cockroaches. It is a decapeptide with the sequence QVNFSPGWGT .

Phylogenetic comparison with other cockroach species shows distinct patterns:

Hypertrehalosaemic factors from the Blaberidae family (including B. giganteus) possess one decapeptide that differs structurally from the two octapeptides found in Blattidae species . This structural difference reflects evolutionary relationships within the Blattaria suborder.

What are the primary physiological functions and metabolic pathways influenced by hypertrehalosaemic factors?

The primary functions of hypertrehalosaemic factors include:

• Trehalose regulation: These factors significantly increase hemolymph trehalose levels, which is the main circulating sugar in insects .

• Adipokinetic activity: They mobilize lipids from the fat body, similar to mammalian glucagon .

• Energy metabolism regulation: During periods of high energy demand, these factors help maintain energy homeostasis.

The metabolic pathway involves:

• Release from corpora cardiaca (neurohemal organs)

• Binding to specific receptors on target tissues

• Activation of glycogenolysis in the fat body

• Inhibition of glycolysis

• Stimulation of trehalose synthesis and release into hemolymph

These pathways are particularly important during flight, starvation, and other energy-demanding processes in insects.

How is recombinant B. giganteus hypertrehalosaemic factor produced for research purposes?

Recombinant B. giganteus hypertrehalosaemic factor is typically produced using yeast expression systems . The production process involves:

• Gene synthesis: Chemical synthesis of the gene encoding the decapeptide sequence

• Vector construction: Cloning into appropriate expression vectors (e.g., pUC57-Kan)

• Expression host transformation: Transformation of the expression system (yeast or E. coli BL21)

• Induction and expression: Culture at optimal conditions (typically 37°C with agitation at 200 rpm)

• Purification: Using techniques such as affinity chromatography

• Quality control: Verification through SDS-PAGE and Western blotting

• Storage: Typically at -20°C or -80°C for extended storage

The recombinant protein typically has >85% purity as determined by SDS-PAGE .

How can recombinant B. giganteus hypertrehalosaemic factor be used in comparative endocrinology studies?

Researchers can leverage recombinant BgHTF in comparative endocrinology through several approaches:

• Cross-species receptor binding studies: Testing activity on receptors from different insect species to evaluate evolutionary conservation of signaling pathways.

• Structure-function relationships: Comparing activity of BgHTF with similar factors from other species:

  Species	Factor	Sequence	Activity Comparison
  B. giganteus	HTF	QVNFSPGWGT	Baseline
  B. discoidalis	HTF	pGlu-Val-Asn-Phe-Ser-Pro-Gly-Trp-Gly-Thr-NH₂	Very similar activity
  Heliothis zea	AKH	Variable	Adipokinetic and hypertrehalosaemic
  Periplaneta americana	M I & M II	Different octapeptides	Different potency profile

• Evolutionary endocrinology: Investigating how these neuropeptides have evolved across insect taxa and their relationship to metabolic adaptations.

• Hormonal cross-talk: Studying interactions between hypertrehalosaemic factors and other hormonal systems in insects, such as juvenile hormone or ecdysteroids.

What research methods are most effective for studying receptor binding of hypertrehalosaemic factors?

Effective methods for studying receptor binding include:

• Radioligand binding assays: Using radiolabeled peptides to determine binding affinity (Kd) and receptor density (Bmax).

• Surface plasmon resonance (SPR): For real-time, label-free detection of binding kinetics.

• FRET/BRET-based assays: For studying receptor-ligand interactions and downstream signaling.

• Functional assays: Measuring physiological responses like trehalose release from fat body explants or cAMP production in receptor-expressing cells.

• Receptor mutagenesis: Identifying critical binding residues through systematic mutation of receptor domains.

How does hypertrehalosaemic factor interact with trehalose metabolism in insect models?

The interaction involves a complex signaling cascade:

• Receptor activation: Binding to G-protein coupled receptors on fat body cells.

• Signal transduction: Activation of adenylyl cyclase and increased cAMP levels.

• Enzymatic activation: Phosphorylation of glycogen phosphorylase and trehalose-6-phosphate synthase.

• Metabolic effects:

  • Increased glycogen breakdown

  • Upregulation of trehalose synthesis

  • Inhibition of glycolysis

  • Enhanced trehalose release into hemolymph

• Regulatory feedback: High trehalose levels eventually suppress further hormone release.

This system is analogous to mammalian glucagon signaling but uniquely adapted to insect physiology where trehalose, not glucose, is the primary circulating sugar.

Recent studies have shown that hypertrehalosaemic factors may also regulate expression of specific cytochrome P450 family members, suggesting broader metabolic effects beyond immediate sugar regulation .

What are the optimal storage and handling conditions for preserving recombinant B. giganteus hypertrehalosaemic factor activity?

For optimal preservation of biological activity:

Important considerations:

• Repeated freezing and thawing significantly reduces activity and should be avoided

• Working aliquots should be prepared and stored at 4°C for no more than one week

• For maximum stability, the lyophilized form has a shelf life of approximately 12 months at -20°C/-80°C compared to 6 months for liquid formulations

What bioassays are recommended for measuring the biological activity of hypertrehalosaemic factors?

Several bioassays can reliably measure hypertrehalosaemic factor activity:

• In vivo trehalose measurement:

  • Inject recombinant factor into test insects

  • Collect hemolymph samples at timed intervals (0, 30, 60, 90 min)

  • Measure trehalose concentration using anthrone reagent method

  • Calculate percent increase over baseline

  Expected results: 2-5 fold increase in hemolymph trehalose depending on dose

• Ex vivo fat body incubation:

  • Isolate fat body tissue from cockroaches

  • Incubate with different concentrations of factor

  • Measure trehalose released into the medium

  • Construct dose-response curves

• Receptor-based assays:

  • Use cells expressing the cloned receptor

  • Measure second messenger (cAMP) production

  • Calculate EC₅₀ values

• Comparative activity assessment:

  Assay Type	Advantages	Limitations	Typical Detection Range
  In vivo trehalose	Physiologically relevant	Higher variability	0.1-10 pmol per insect
  Fat body incubation	Controlled conditions	Less physiological context	1 nM - 1 μM
  Receptor-based	High throughput	Artificial system	0.1 nM - 10 μM

• Activity validation: Compare activity with established standards such as natural extracts from corpora cardiaca.

How can HPLC be optimized for isolation and characterization of natural hypertrehalosaemic factors?

HPLC optimization for hypertrehalosaemic factor isolation requires specific conditions:

• Sample preparation:

  • Dissect corpora cardiaca from cockroaches

  • Homogenize in acidified methanol (80% methanol, 1% acetic acid)

  • Centrifuge at 10,000g for 10 minutes

  • Collect supernatant and dry under vacuum

  • Reconstitute in starting mobile phase

• HPLC parameters:

  • Column: C18 reverse-phase (typically 4.6 x 250 mm, 5 μm)

  • Mobile phase A: 0.1% TFA in water

  • Mobile phase B: 0.1% TFA in acetonitrile

  • Gradient: 10-60% B over 30 minutes

  • Flow rate: 1 ml/min

  • Detection: UV at 214 nm and 280 nm

• Verification techniques:

  • Mass spectrometry for molecular weight determination

  • Edman degradation after deblocking with pyroglutamate aminopeptidase for sequence confirmation

  • Bioassay of collected fractions for activity confirmation

This methodology has been successfully used for isolation of hypertrehalosaemic factors from various cockroach species with high yield and purity .

What approaches are recommended for comparative studies between native and recombinant hypertrehalosaemic factors?

For rigorous comparative studies, researchers should consider:

• Structural comparison:

  • Circular dichroism spectroscopy to compare secondary structure

  • Mass spectrometry to verify exact molecular weight

  • N-terminal sequencing to confirm sequence identity

• Functional comparison:

  • Parallel bioassays using identical conditions

  • Dose-response curves to determine EC₅₀ values

  • Receptor binding studies using both preparations

• Experimental design considerations:

  • Use multiple biological replicates (n≥5)

  • Include proper positive and negative controls

  • Perform blinded analyses when possible

  • Test across different physiological states of test insects

• Potential difference analysis:

  Parameter	Possible Differences	Testing Method
  Post-translational modifications	N-terminal pyroglutamate, C-terminal amidation	Mass spectrometry
  Folding/conformation	Secondary structure variations	Circular dichroism
  Biological half-life	Stability in hemolymph	In vivo clearance studies
  Receptor binding kinetics	kon/koff rates	Surface plasmon resonance

• Statistical analysis: Apply appropriate statistical tests (ANOVA with post-hoc tests) to determine if differences between native and recombinant factors are significant.

The recombinant factor should ideally demonstrate identical chromatographic and biological properties as the natural peptide for research validity .

How can recombinant hypertrehalosaemic factors be used in insect physiology and comparative metabolism research?

Recombinant hypertrehalosaemic factors offer versatile research applications:

• Metabolic regulation studies:

  • Investigation of trehalose metabolism regulation in different insect orders

  • Comparative analysis of energy mobilization across species

  • Examination of metabolic adaptations to environmental stress

• Evolutionary biology:

  • Study of molecular evolution of peptide hormones

  • Investigation of receptor-ligand co-evolution

  • Reconstruction of ancestral hormone functions

• Physiological adaptation research:

  • Role in diapause and overwintering

  • Function during metamorphosis

  • Involvement in stress responses

• Disease vector biology:

  • Energy metabolism in disease vectors like tsetse flies

  • Potential targets for vector control strategies

  • Comparison with metabolism in parasites they transmit, such as Trypanosoma brucei

• Comparative endocrinology across model systems:

  Insect Group	HTF Function	Research Application
  Cockroaches	Primary energy mobilization	Basic metabolic regulation
  Flies (Diptera)	Flight energy	Applied vector biology
  Moths/Butterflies	Diapause preparation	Seasonal adaptation
  Beetles	Stress response	Environmental physiology

What techniques are most effective for investigating the signaling pathways activated by hypertrehalosaemic factors?

Several complementary approaches provide comprehensive insight:

• Molecular techniques:

  • RNA interference to silence receptor or downstream components

  • CRISPR-Cas9 for precise genetic manipulation

  • Fluorescent reporter constructs for visualizing pathway activation

• Biochemical methods:

  • Phosphoproteomics to identify phosphorylation cascades

  • Immunoprecipitation to detect protein-protein interactions

  • Western blotting for activation of specific pathway components

• Cell biology approaches:

  • Calcium imaging for detecting intracellular calcium dynamics

  • cAMP/cGMP assays for measuring second messenger production

  • Confocal microscopy for tracking receptor internalization

• Pharmacological tools: Specific inhibitors of pathway components can help delineate the signaling cascade.

This multi-level analysis allows researchers to construct comprehensive models of hypertrehalosaemic factor signaling that connect receptor activation to physiological outcomes.

How does environmental stress affect hypertrehalosaemic factor production and function in insects?

Environmental stressors significantly influence hypertrehalosaemic factor dynamics:

• Starvation:

  • Increases factor release from corpora cardiaca

  • Enhances target tissue sensitivity to the hormone

  • Elevates receptor expression in fat body

• Temperature stress:

  • Cold exposure typically increases factor production

  • Heat shock can temporarily suppress the response

  • Recovery phases show enhanced signaling

• Dehydration:

  • May increase factor concentration in hemolymph

  • Changes receptor sensitivity

  • Interacts with other hormonal systems

• Oxidative stress:

  • Can modify the peptide through oxidation

  • Alters receptor binding properties

  • May trigger compensatory factor production

• Research approaches:

  Stress Type	Measurement Method	Expected Change
  Starvation	ELISA/MS quantification	2-5× increase
  Cold stress	qPCR of biosynthetic enzymes	Upregulation
  Dehydration	Bioassay of hemolymph samples	Variable response
  Combined stressors	Metabolomics	Complex interactions

Understanding these stress responses has implications for insect adaptation to changing environments and potential applications in pest management strategies.

What controls should be included when testing biological activity of recombinant hypertrehalosaemic factors?

Rigorous experimental design requires appropriate controls:

• Negative controls:

  • Vehicle-only treatment (buffer used for reconstitution)

  • Heat-inactivated recombinant factor (95°C for 10 minutes)

  • Irrelevant peptide of similar size (e.g., scrambled sequence)

• Positive controls:

  • Natural extract from corpora cardiaca

  • Well-characterized reference peptide (e.g., P. americana AKH)

  • Synthetic peptide with confirmed activity

• Procedural controls:

  • Time-matched sampling without treatment

  • Dose-response series to establish linear range

  • Internal standard for quantification

• Validation approaches:

  • Receptor antagonist to block specific effects

  • Multiple independent bioassays

  • Cross-checking results with different methodologies

• Control matrix:

  Control Type	Purpose	Example
  Vehicle	Control for buffer effects	Same volume of reconstitution buffer
  Dose-response	Establish linearity	5-7 concentrations spanning 3 logs
  Sequence specificity	Confirm structure-function	Single amino acid substitution variants
  Tissue specificity	Verify target tissue	Compare fat body vs. muscle response

A well-designed control strategy ensures that observed effects are specifically attributable to the biological activity of the recombinant factor.

How can researchers troubleshoot issues with recombinant hypertrehalosaemic factor activity?

When facing activity issues, consider this systematic troubleshooting approach:

• Storage and handling problems:

  • Verify storage conditions (-20°C/-80°C recommended)

  • Check for excessive freeze-thaw cycles

  • Examine buffer composition and pH

• Structural integrity issues:

  • Confirm molecular weight by mass spectrometry

  • Verify amino acid sequence

  • Check for oxidation of sensitive residues (e.g., Trp)

• Expression system considerations:

  • Evaluate post-translational modifications

  • Assess folding and conformation

  • Consider alternative expression systems

• Bioassay troubleshooting:

  • Verify assay sensitivity with positive controls

  • Check for inhibitors in the preparation

  • Optimize timing of measurements

• Methodological adjustments:

  Problem	Possible Cause	Solution
  No activity	Protein degradation	Fresh preparation, protease inhibitors
  Reduced potency	Partial denaturation	Optimize buffer conditions
  Variable results	Inconsistent reconstitution	Standardize reconstitution protocol
  Precipitation	Incompatible buffer	Adjust pH or ionic strength
  Loss during storage	Adsorption to container	Add carrier protein (0.1% BSA)

• Documentation: Maintain detailed records of all troubleshooting steps and outcomes to establish optimal conditions for future work.

What are the key considerations for experimental design when studying species-specific differences in hypertrehalosaemic factor function?

For robust comparative studies across species:

• Phylogenetic sampling:

  • Include representative species from different families

  • Consider evolutionary relationships

  • Sample species with different ecological niches

• Standardized methodology:

  • Use identical extraction and purification protocols

  • Apply consistent bioassay conditions

  • Standardize dosing based on body mass

• Cross-species testing:

  • Test each factor on multiple species

  • Construct activity matrices for all combinations

  • Analyze phylogenetic patterns in responses

• Molecular characterization:

  • Sequence determination for all factors

  • Receptor sequencing from each species

  • Structure-function analysis of key motifs